Arpan Satsangi, MD
Urology · San Antonio, TXNPI 1861927931
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,827 of the $14,066 with a category attached, or 62.8%. 19 manufacturers reported payments, led by Coloplast at 34.3% of the total. Reporting peaked in 2022 at $8,098 and has fallen 65.2% since, to $2,816 in 2025.
Across 135 payments — averaging $104.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$5K
- Teleflex LLC$3K
- Boston Scientific$3K
- Medtronic$1K
- Profound Medical Corp.$383
- Procept Biorobotics Corporation$231
- plus $1K from 13 others
What the payments were for
- Travel & lodging$8,82763%
- Food & beverage$5,23937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 30 | $4,819 |
| Teleflex LLC | 34 | $3,401 |
| Boston Scientific | 24 | $3,063 |
| Medtronic | 16 | $1,134 |
| Profound Medical Corp. | 2 | $383 |
| Procept Biorobotics Corporation | 4 | $231 |
| Axonics, Inc. | 4 | $194 |
| Smith+Nephew | 5 | $136 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $124 |
| Urovant Sciences Inc | 1 | $109 |
| Telix Pharmaceuticals | 3 | $108 |
| GSK | 1 | $108 |
| Sumitomo Pharma America, Inc. | 3 | $82 |
| Antares Pharma, Inc. | 1 | $50 |
| Biotissue Holdings Inc. | 2 | $35 |
| ABC Home Medical Supply, Inc. | 1 | $27 |
| Laborie Medical Technologies Corp. | 1 | $26 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESTORELLE$2,150
- ALTIS$1,519
- UroLift System$1,251
- UroLift$1,134
- INTERSTIM$671
- rezum Generator$659
- TITAN$386
- Tulsa-Pro$383
- AMS 700$182
- NEFFY$124
- GEMTESA$109
- GENERAL ERECTILE DYSFUNCTION$108
- SHINGRIX$108
How this compares
$14,066 in reported general payments places this provider in the 80th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 22 | $11,280 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 12 | $1,823 |
| Trospium Chloride | 37 | $1,353 |
| Tamsulosin Hcl | 89 | $600 |
| Dutasteride | 26 | $598 |
| Finasteride | 44 | $350 |
| Ciprofloxacin Hcl | 11 | $39 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Other urology in San Antonio
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
- Jose de la CerdaSan Antonio$278K
- Naveen KellaSan Antonio$84K
- Christopher CantrillSan Antonio$73K
- Robert SvatekSan Antonio$51K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.